REG - Celtic PLC - Issued share capital

CelticAnnouncement

19/02/2025 14:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250219:nRSS7435Xa&default-theme=true

RNS Number : 7435X  Celtic PLC  19 February 2025

CELTIC PLC

Issued share capital

 

As a result of the conversion of 35,000 Convertible Cumulative Preference
Shares of 60p each, Celtic PLC's issued share capital as at 18 February 2025
was as follows:

 

94,878,668           Ordinary Shares of 1p each ("Ordinary
Shares")

12,654,884           Convertible Preferred Ordinary Shares of 100p
each ("CPO Shares")

15,626,623           Convertible Cumulative Preference Shares of 60p
each ("CCP Shares")

694,141,926        Deferred Shares of 1p each

 

CCP Shares do not carry voting rights. Deferred Shares are not listed, are not
transferable and carry no voting rights or substantive economic rights.

 

The above figures for Ordinary Shares and CPO Shares may be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change in
their interest in voting rights under the FCA's Disclosure Guidance and
Transparency Rules.

 

Application has been made for the admission of the 35,000 new Ordinary Shares
of 1p each arising from these conversions ("New Ordinary Shares") to trading
on AIM. It is expected that dealings in these New Ordinary Shares, which will
rank pari passu in all respects with the existing Ordinary Shares of the
Company, is expected to commence on 25 February 2025.

 

Enquiries:

 

Company

Joanne McNairn, Company Secretary                     0141
551 4330

 

Canaccord Genuity Limited

Simon Bridges, Nominated Adviser
                     0207 523 8350

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CONTLMITMTMBBTA